Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Head and Neck Cancer

  Free Subscription


Articles published in J Nucl Med

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    January 2012
  1. CHANG KP , Tsang NM, Liao CT, Hsu CL, et al
    Prognostic Significance of 18F-FDG PET Parameters and Plasma Epstein-Barr Virus DNA Load in Patients with Nasopharyngeal Carcinoma.
    J Nucl Med. 2012;53:21-8.
    PubMed     Text format     Related articles    Abstract available



  2. HATT M , Le Pogam A, Visvikis D, Pradier O, et al
    Impact of Partial-Volume Effect Correction on the Predictive and Prognostic Value of Baseline 18F-FDG PET Images in Esophageal Cancer.
    J Nucl Med. 2012;53:12-20.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  3. KAUHANEN S , Schalin-Jantti C, Seppanen M, Kajander S, et al
    Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer.
    J Nucl Med. 2011.
    PubMed     Text format     Related articles    Abstract available



  4. ZIESSMAN HA
    General nuclear medicine.
    J Nucl Med. 2011;52:20N-8N.
    PubMed     Text format     Related articles   



    October 2011
  5. KIM JE , Ahn BC, Hwang MH, Jeon YH, et al
    Combined RNA Interference of Hexokinase II and 131I-Sodium Iodide Symporter Gene Therapy for Anaplastic Thyroid Carcinoma.
    J Nucl Med. 2011.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  6. HEUVELING DA , Visser GW, Baclayon M, Roos WH, et al
    89Zr-Nanocolloidal Albumin-Based PET/CT Lymphoscintigraphy for Sentinel Node Detection in Head and Neck Cancer: Preclinical Results.
    J Nucl Med. 2011.
    PubMed     Text format     Related articles    Abstract available



  7. WILD D , Fani M, Behe M, Brink I, et al
    First clinical evidence that imaging with somatostatin receptor antagonists is feasible.
    J Nucl Med. 2011;52:1412-7.
    PubMed     Text format     Related articles    Abstract available



  8. DAUER LT , Zanzonico P, Tuttle RM, Quinn DM, et al
    The Japanese tsunami and resulting nuclear emergency at the Fukushima Daiichi power facility: technical, radiologic, and response perspectives.
    J Nucl Med. 2011;52:1423-32.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  9. MEYER ZUM BUSCHENFELDE C , Herrmann K, Schuster T, Geinitz H, et al
    18F-FDG PET-Guided Salvage Neoadjuvant Radiochemotherapy of Adenocarcinoma of the Esophagogastric Junction: The MUNICON II Trial.
    J Nucl Med. 2011.
    PubMed     Text format     Related articles    Abstract available



  10. ORA M , P M, Jain S, Barai S, et al
    The need for a low-expense universally acceptable rhTSH protocol.
    J Nucl Med. 2011;52:1166.
    PubMed     Text format     Related articles   



    June 2011
  11. CHOI SH , Paeng JC, Sohn CH, Pagsisihan JR, et al
    Correlation of 18F-FDG Uptake with Apparent Diffusion Coefficient Ratio Measured on Standard and High b Value Diffusion MRI in Head and Neck Cancer.
    J Nucl Med. 2011.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  12. GOLDSMITH SJ
    The real cost of theoretic risk avoidance: the need to challenge unsubstantiated concerns about (131)I therapy.
    J Nucl Med. 2011;52:681-2.
    PubMed     Text format     Related articles   



    April 2011
  13. HIGASHI T , Nishii R, Yamada S, Nakamoto Y, et al
    Delayed Initial Radioactive Iodine Therapy Resulted in Poor Survival in Patients with Metastatic Differentiated Thyroid Carcinoma: A Retrospective Statistical Analysis of 198 Cases.
    J Nucl Med. 2011.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  14. GREGOIRE V , Chiti A
    Molecular imaging in radiotherapy planning for head and neck tumors.
    J Nucl Med. 2011;52:331-4.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  15. WU HB , Wang QS, Wang MF, Zhen X, et al
    Preliminary Study of 11C-Choline PET/CT for T Staging of Locally Advanced Nasopharyngeal Carcinoma: Comparison with 18F-FDG PET/CT.
    J Nucl Med. 2011.
    PubMed     Text format     Related articles    Abstract available



  16. TIXIER F , Le Rest CC, Hatt M, Albarghach N, et al
    Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer.
    J Nucl Med. 2011.
    PubMed     Text format     Related articles    Abstract available



  17. LIAO CT , Wang HM, Huang SF, Chen IH, et al
    PET and PET/CT of the Neck Lymph Nodes Improves Risk Prediction in Patients with Squamous Cell Carcinoma of the Oral Cavity.
    J Nucl Med. 2011;52:180-7.
    PubMed     Text format     Related articles    Abstract available



  18. WALTER MA , Benz MR, Hildebrandt IJ, Laing RE, et al
    Metabolic imaging allows early prediction of response to vandetanib.
    J Nucl Med. 2011;52:231-40.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  19. DE MEER SG , Vriens MR, Zelissen PM, Borel Rinkes IH, et al
    The Role of Routine Diagnostic Radioiodine Whole-Body Scintigraphy in Patients with High-Risk Differentiated Thyroid Cancer.
    J Nucl Med. 2010.
    PubMed     Text format     Related articles    Abstract available




  20. Patient release issue reopened.
    J Nucl Med. 2010;51:13N.
    PubMed     Text format     Related articles   




  21. Professional groups respond.
    J Nucl Med. 2010;51:13N.
    PubMed     Text format     Related articles   



    November 2010
  22. MALIK V , Lucey JA, Duffy GJ, Wilson L, et al
    Early Repeated 18F-FDG PET Scans During Neoadjuvant Chemoradiation Fail to Predict Histopathologic Response or Survival Benefit in Adenocarcinoma of the Esophagus.
    J Nucl Med. 2010.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  23. SHI K , Souvatzoglou M, Astner ST, Vaupel P, et al
    Quantitative assessment of hypoxia kinetic models by a cross-study of dynamic 18F-FAZA and 15O-H2O in patients with head and neck tumors.
    J Nucl Med. 2010;51:1386-94.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  24. GREWAL RK , Tuttle RM, Fox J, Borkar S, et al
    The Effect of Posttherapy 131I SPECT/CT on Risk Classification and Management of Patients with Differentiated Thyroid Cancer.
    J Nucl Med. 2010.
    PubMed     Text format     Related articles    Abstract available



  25. HATT M , Cheze-Le Rest C, Aboagye EO, Kenny LM, et al
    Reproducibility of 18F-FDG and 3'-Deoxy-3'-18F-Fluorothymidine PET Tumor Volume Measurements.
    J Nucl Med. 2010.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  26. LASSMANN M , Hanscheid H, Gassen D, Biko J, et al
    In Vivo Formation of {gamma}-H2AX and 53BP1 DNA Repair Foci in Blood Cells After Radioiodine Therapy of Differentiated Thyroid Cancer.
    J Nucl Med. 2010.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  27. NGUYEN NC , Fajnwak P, Osman MM, Farghaly HR, et al
    18F-FDG PET for Routine Posttreatment Surveillance in Oral and Oropharyngeal Squamous Cell Carcinoma.
    J Nucl Med. 2010.
    PubMed     Text format     Related articles   



  28. HOEBEN BA , Kaanders JH, Franssen GM, Troost EG, et al
    PET of Hypoxia with 89Zr-Labeled cG250-F(ab')2 in Head and Neck Tumors.
    J Nucl Med. 2010.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: